NVO Novo Nordisk A/ScompanySEC Filings & Insider Trading Activity 2026
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
Frequently Asked Questions
Where can I find NVO insider trading activity (Form 4)?
SignalX aggregates every NVO Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does NVO file with the SEC?
Novo Nordisk A/S (NVO) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new NVO filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Novo Nordisk A/S (NVO).
What is NVO's SEC CIK number?
Novo Nordisk A/S (NVO)'s SEC CIK (Central Index Key) number is 353278. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 353278 to look up all NVO filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find NVO return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Novo Nordisk A/S (NVO) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Novo Nordisk A/S SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 31+ filings.